Novo Nordisk Shares Jump After Hims & Hers Scraps Plan For Copycat Weight-Loss Pill
WSJ·2026-02-09 09:40

Group 1 - The telehealth provider has decided to discontinue access to a compounded version of Wegovy due to legal threats from Novo Nordisk [1]

Novo Nordisk Shares Jump After Hims & Hers Scraps Plan For Copycat Weight-Loss Pill - Reportify